The effect of hypertension comorbidity on the development of hypoglycemia in patients with type 2 diabetes

被引:1
|
作者
Hoang T. Tran
Bandit Thinkhamrop
Wongsa Laohasiriwong
Cameron Hurst
机构
[1] Khon Kaen University,Faculty of Public Health
[2] Thai Nguyen University of Medicine and Pharmacy,Faculty of Public Health
[3] Khon Kaen University,Clinical Epidemiology Unit, Faculty of Medicine
关键词
Type 2 diabetes; Hypertension; Hypoglycemia;
D O I
暂无
中图分类号
学科分类号
摘要
Type 2 diabetes mellitus (T2DM) patients require close glycemic control to decrease complications especially the incidence of hypoglycemia. T2DM patients with hypertension comorbidity may require extra monitoring to control this complication. This study aims to investigate the effect of hypertension comorbidity on the development of hypoglycemia in T2DM patients. A national representative survey of T2DM patients from 602 hospitals across Thailand during 2011–2012 was conducted. Binary logistic mixed effect regression was used to estimate the effect of hypertension along with other risk factors on the development of hypoglycemia. Of the 55,797 T2DM patient sample, 55.35 % were hypertensive. The prevalence of hypoglycemia in T2DM with hypertension comorbidity (4.87 %) was higher than that without hypertension (3.87 %). After adjusting for confounders, gender, age, health care coverage, body mass index, diabetes duration, diabetes medication, and microvascular complications were significantly associated with hypoglycemia. T2DM patients with a hypertension comorbidity had 1.12 times the odds of developing hypoglycemia than patients without hypertension (95 % confidence interval (CI) 1.00, 1.25; P < 0.05). Hypertension comorbidity is associated with hypoglycemia among patients with type 2 diabetes.
引用
收藏
页码:598 / 603
页数:5
相关论文
共 50 条
  • [41] Orthostatic hypertension in patients with type 2 diabetes
    Yoshinari, M
    Wakisaka, M
    Nakamura, U
    Yoshioka, M
    Uchizono, Y
    Iwase, M
    DIABETES CARE, 2001, 24 (10) : 1783 - 1786
  • [42] Changes in peripapillary microvasculature in patients with type 2 diabetes patients: effect of systemic hypertension
    Sung, Jae-Yun
    Lee, Kook-Hyung
    Jun, Ji-Ho
    Lee, Min-Woo
    SCIENTIFIC REPORTS, 2023, 13 (01):
  • [43] Changes in peripapillary microvasculature in patients with type 2 diabetes patients: effect of systemic hypertension
    Jae-Yun Sung
    Kook-Hyung Lee
    Ji-Ho Jun
    Min-Woo Lee
    Scientific Reports, 13 (1)
  • [44] Effect of 2 weeks of theophylline on glucose counterregulation in patients with type 1 diabetes and unawareness of hypoglycemia
    de Galan, BE
    Tack, CJ
    Lenders, JW
    Lutterman, JA
    Smits, P
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2003, 74 (01) : 77 - 84
  • [45] HYPOGLYCEMIA IN TYPE-2 DIABETES
    BIELEFELDT, K
    MEDIZINISCHE KLINIK, 1990, 85 (03) : 117 - 120
  • [46] Hypoglycemia and Comorbidities in Type 2 Diabetes
    Alice P. S. Kong
    Juliana C. N. Chan
    Current Diabetes Reports, 2015, 15
  • [47] Preventing Hypoglycemia in Type 2 Diabetes
    Lash, Robert W.
    Lucas, Deborah O.
    Illes, Judit
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2018, 103 (04): : 1265 - 1268
  • [48] Hypoglycemia and Comorbidities in Type 2 Diabetes
    Kong, Alice P. S.
    Chan, Juliana C. N.
    CURRENT DIABETES REPORTS, 2015, 15 (10)
  • [49] The effect of rosiglitazone on lipoprotein(a) and homocysteine levels in patients with hypertension and Type 2 diabetes
    Sarafidis, P
    Lasaridis, A
    Nilsson, P
    Hitoglou-Makedou, A
    Pliakos, C
    Tziolas, I
    Hatzistavri, L
    Stafilas, P
    Tourkantonis, A
    JOURNAL OF HYPERTENSION, 2005, 23 : S96 - S96
  • [50] The Nursing Effect of Individualized Management on Patients With Diabetes Mellitus Type 2 and Hypertension
    Li, Ran
    Xu, Weiwei
    Yang, Ping
    Tan, Lian
    Ling, Zhiyu
    Gan, Xiuni
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13